These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33419728)

  • 1. Why are certain age bands used for children in paediatric studies of medicines?
    Hoppu K; Fonseca H
    Arch Dis Child; 2021 Jul; 106(7):631-635. PubMed ID: 33419728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improving drug licensing for children and adolescents : Position paper from the More Medicines for Minors Symposion 8 June 2015 in Bonn].
    Riedel C; Lehmann B; Broich K; Sudhop T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Dec; 59(12):1587-1592. PubMed ID: 27778087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
    Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
    Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
    Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licensing and labelling of drugs in a paediatric oncology ward.
    van den Berg H; Tak N
    Br J Clin Pharmacol; 2011 Sep; 72(3):474-81. PubMed ID: 21453298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of legislation on drug substances used off-label in paediatric wards--a nationwide study.
    Haslund-Krog S; Mathiasen R; Christensen HR; Holst H
    Eur J Clin Pharmacol; 2014 Apr; 70(4):445-52. PubMed ID: 24398969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More medicines for children: impact of the EU paediatric regulation.
    Nordenmalm S; Tomasi P; Pallidis C
    Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitudes and experiences of community pharmacists towards paediatric off-label prescribing: a prospective survey.
    Stewart D; Rouf A; Snaith A; Elliott K; Helms PJ; McLay JS
    Br J Clin Pharmacol; 2007 Jul; 64(1):90-5. PubMed ID: 17324238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for unlicensed and off-label drug use in children outside the hospital.
    Schirm E; Tobi H; de Jong-van den Berg LT
    Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unlicensed and off-label use of medicines at a neonatology clinic in Italy.
    Dell'Aera M; Gasbarro AR; Padovano M; Laforgia N; Capodiferro D; Solarino B; Quaranta R; Dell'Erba AS
    Pharm World Sci; 2007 Aug; 29(4):361-7. PubMed ID: 17351821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three years of paediatric regulation in the European Union.
    Olski TM; Lampus SF; Gherarducci G; Saint Raymond A
    Eur J Clin Pharmacol; 2011 Mar; 67(3):245-52. PubMed ID: 21286912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants for drug prescribing to children below the minimum licensed age.
    't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Stricker BH
    Eur J Clin Pharmacol; 2003 Feb; 58(10):701-5. PubMed ID: 12610748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
    Hwang TJ; Tomasi PA; Bourgeois FT
    PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Medicines for children and "off-label use" 5 years after implementation of the Paediatric Regulation (EC) No 1901/2006. An interim analyis].
    Afentaki A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Sep; 57(9):1111-9. PubMed ID: 25139386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
    't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
    Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The European paediatric legislation: benefits and perspectives.
    Rocchi F; Paolucci P; Ceci A; Rossi P
    Ital J Pediatr; 2010 Aug; 36():56. PubMed ID: 20716337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.